Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Isopropyl 3 Amino 4 Methylpyridine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel L-alanine catalyzed route improves yield and purity for KRAS G12C inhibitor intermediates, offering cost-effective scale-up solutions.
Patent CN113603636A details a cost-effective Nickel-catalyzed route for 2-isopropyl-3-amino-4-methylpyridine, offering significant supply chain advantages.
Patent CN112479993A details a cost-effective iron-catalyzed synthesis for KRAS inhibitor intermediates, offering significant supply chain and purity advantages for API manufacturers.
Discover a scalable, eco-friendly synthesis route for KRAS inhibitor intermediate with 33% yield. Reduce costs and supply chain risks for your API production.